Panacea Biotec Limited (NSE:PANACEABIO)
India · Delayed Price · Currency is INR 296.05
-23.75 (-7.43%)
Mar 30, 2026, 3:30 PM IST
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 18.13 billion as of March 31, 2026. Its market cap has decreased by -20.69% in one year.
Market Cap
18.13B
Enterprise Value
17.47B
Revenue
6.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
296.05
Market Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has decreased from 21.08B to 18.13B, a decrease of -13.96%. That is a compound annual growth rate of -0.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 18.13B | -21.33% |
| Dec 31, 2025 | 23.05B | -10.11% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 598.96B |
| Anthem Biosciences | 382.71B |
| OneSource Specialty Pharma | 165.87B |
| Concord Biotech | 106.16B |
| Blue Jet Healthcare | 59.64B |
| Supriya Lifescience | 47.29B |
| Zota Health Care | 35.82B |
| Dishman Carbogen Amcis | 22.37B |